NCT01888952 2017-02-27Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)The University of Texas Health Science Center at San AntonioPhase EARLY_PHASE1 Completed10 enrolled 4 charts